Name: Enliven Therapeutics, Inc. (ELVN) Balance Sheet
Creator: FinSpry

Enliven Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Enliven Therapeutics, Inc. (ELVN) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	124.12	100.14	75.54	90.28	130.37
Short-Term Investments	189.32	153.01	0.00	0.00	0.00
Cash & Short-Term Investments	313.44	253.15	75.54	90.28	130.37
Accounts Receivable	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	4.63	12.95	2.22	0.65	0.06
Total Current Assets	318.13	266.15	77.75	92.70	130.59
Non-Current Assets
Property, Plant & Equipment (Net)	0.46	1.06	1.52	0.78	0.42
Other Non-Current Assets	7.18	4.09	0.05	0.18	0.09
Total Non-Current Assets	7.63	5.72	5.55	0.95	0.44
Total Assets	325.76	271.87	83.30	93.65	131.00
Current Liabilities
Accounts Payable	1.34	0.53	3.44	2.36	0.81
Accrued Liabilities	14.37	11.34	4.32	1.68	0.43
Other Current Liabilities	0.20	10.36	1.64	4.60	0.14
Total Current Liabilities	15.92	25.89	9.72	7.21	1.48
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.41	0.00
Other Non-Current Liabilities	0.00	0.07	0.38	0.71	0.08
Total Non-Current Liabilities	0.00	0.07	150.41	0.41	0.16
Total Liabilities	15.92	25.96	10.37	7.62	1.56
Stockholders' Equity
Common Stock	0.05	0.04	0.00	0.00	0.00
Retained Earnings	-243.47	-154.45	-82.86	-147.51	-20.46
Accumulated Other Comprehensive Income	0.06	0.14	0.00	0.00	0.00
Additional Paid-in Capital	553.21	400.17	6.04	233.52	180.53
Shares Outstanding	48.94	41.29	41.10	41.10	0.00
Total Stockholders' Equity	309.85	245.91	72.92	86.03	129.45
Total Liabilities & Equity	325.76	271.87	83.30	93.65	90.84